Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- befree-2016 importedOn "2016-02-19" NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_assertion wasGeneratedBy ECO_0000203 NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_assertion wasDerivedFrom befree-2016 NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_assertion SIO_000772 22525818 NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_assertion evidence source_evidence_literature NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.
- NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_assertion description "[Angiotensin II type I receptor and miR-155 in endometrial cancers: synergistic antiproliferative effects of anti-miR-155 and losartan on endometrial cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976800.RA_cRwcUwSLwzXbKR-ELj9qbISiH4_HkuhMWAoShbW9Tc130_provenance.